1. Cutaneous adverse events in patients treated with BRAF inhibitor‐based therapies for metastatic melanoma for longer than 52 weeks. (1st January 2015) Authors: Anforth, R.; Carlos, G.; Clements, A.; Kefford, R.; Fernandez‐Peñas, P. Journal: British journal of dermatology Issue: Volume 172:Number 1(2015:Jan.) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cutaneous adverse events in patients treated with BRAF inhibitor‐based therapies for metastatic melanoma for longer than 52 weeks. (21st November 2014) Authors: Anforth, R.; Carlos, G.; Clements, A.; Kefford, R.; Fernandez‐Peñas, P. Journal: British journal of dermatology Issue: Volume 172:Number 1(2015:Jan.) Page Start: 239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Non‐evolving linear facial plaque. (12th April 2013) Authors: Mohd Affandi, A.; Anforth, R.; Chou, S.; Fernadez‐Peñas, P. Journal: Clinical and experimental dermatology Issue: Volume 38:Number 6(2013) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors. (December 2013) Authors: Anforth, R.; Blumetti, T.C.M.P.; Clements, A.; Kefford, R.; Long, G.V.; Fernandez‐Peñas, P. Journal: British journal of dermatology Issue: Volume 169:Number 6(2013:Dec.) Page Start: 1310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Treatment‐specific utility weightings are needed for cost–utility analysis in metastatic melanoma. (1st February 2016) Authors: Sebaratnam, D.F.; Anforth, R.; Fernández‐Peñas, P. Journal: British journal of dermatology Issue: Volume 174:Number 2(2016) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Treatment‐specific utility weightings are needed for cost–utility analysis in metastatic melanoma. (9th January 2016) Authors: Sebaratnam, D.F.; Anforth, R.; Fernández‐Peñas, P. Journal: British journal of dermatology Issue: Volume 174:Number 2(2016) Page Start: 462 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Variation in the length and structure of reports written by reporting radiographers: A retrospective study. Issue 4 (November 2018) Authors: Manning-Stanley, A.S.; Bonnett, L.; Mellett, T.; Herreran, J.R.; Anforth, R. Journal: Radiography Issue: Volume 24:Issue 4(2018) Page Start: 383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗